Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8429 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8333 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8273 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8224 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8105 |
Intermediate Similarity |
NPD37 |
Approved |
0.8077 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8065 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8052 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8038 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7949 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7937 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7872 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.784 |
Intermediate Similarity |
NPD7228 |
Approved |
0.784 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7821 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD1608 |
Approved |
0.777 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7733 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7724 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7683 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7673 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD228 |
Approved |
0.7628 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7603 |
Intermediate Similarity |
NPD943 |
Approved |
0.7595 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.759 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7554 |
Intermediate Similarity |
NPD17 |
Approved |
0.7551 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7545 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7533 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD919 |
Approved |
0.75 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD1653 |
Approved |
0.75 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7482 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7467 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7465 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7419 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7412 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD9545 |
Approved |
0.74 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7351 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7337 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7329 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7222 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7215 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7211 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7203 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7203 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7161 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD826 |
Approved |
0.7133 |
Intermediate Similarity |
NPD825 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7124 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7108 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7103 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7045 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7034 |
Intermediate Similarity |
NPD9717 |
Approved |
0.703 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD9493 |
Approved |
0.702 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7017 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7007 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD920 |
Approved |
0.7 |
Intermediate Similarity |
NPD3268 |
Approved |
0.6993 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6987 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6972 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD257 |
Approved |
0.6959 |
Remote Similarity |
NPD258 |
Approved |
0.6957 |
Remote Similarity |
NPD3686 |
Approved |
0.6957 |
Remote Similarity |
NPD3687 |
Approved |
0.6954 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.695 |
Remote Similarity |
NPD7157 |
Approved |
0.6948 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6948 |
Remote Similarity |
NPD3748 |
Approved |
0.6948 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD4626 |
Approved |
0.6934 |
Remote Similarity |
NPD2684 |
Approved |
0.6933 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6918 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6914 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6901 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6897 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6892 |
Remote Similarity |
NPD1203 |
Approved |
0.6887 |
Remote Similarity |
NPD411 |
Approved |
0.6887 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6879
|
Remote Similarity |
NPD2654 |
Approved |